These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2447434)

  • 21. Do beta-blockers alter lipids and what are the consequences?
    Holtzman E; Rosenthal T; Goldbourt U; Segal P
    J Cardiovasc Pharmacol; 1987; 10 Suppl 2():S86-92; discussion S93. PubMed ID: 2481177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term therapy with terazosin may improve glucose and lipid metabolism in hypertensives: a multicenter prospective study.
    Shionoiri H; Gotoh E; Ito T; Hata T; Iwatsubo H; Takegawa K; Ogihara T; Mikami H; Ikegami H; Otsuka A
    Am J Med Sci; 1994 Feb; 307 Suppl 1():S91-5. PubMed ID: 7908168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular effects of the novel Ca2+-sensitiser EMD 57033 in pigs at rest and during treadmill exercise.
    Stubenitsky R; van der Weerd RW; Haitsma DB; Verdouw PD; Duncker DJ
    Br J Pharmacol; 1997 Dec; 122(7):1257-70. PubMed ID: 9421271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha 1-blockers, their antihypertensive efficacy and effects on lipids and lipoprotein.
    Kincaid-Smith P
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():75-83. PubMed ID: 2575178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes in lipids and lipoproteins caused by the beta-blocking agents used as antihypertensives].
    Rouffy J; Chanu B; Bakir R; Sauvanet JP
    J Pharmacol; 1983; 14 Suppl 2():183-99. PubMed ID: 6138467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum lipid changes on low salt diet. Effects of alpha 1-adrenergic blockade.
    Fliser D; Nowack R; Allendorf-Ostwald N; Kohl B; Hübinger A; Ritz E
    Am J Hypertens; 1993 Apr; 6(4):320-4. PubMed ID: 8099492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New mutant rabbit strain with hypercholesterolemia and atherosclerotic lesions produced by serial inbreeding.
    Kurosawa T; Kusanagi M; Yamasaki Y; Senga Y; Yamamoto T
    Lab Anim Sci; 1995 Aug; 45(4):385-92. PubMed ID: 7474877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of effects on lipid metabolism of antihypertensive drugs with alpha- and beta-adrenergic antagonist properties.
    Leren P
    Am J Med; 1987 Jan; 82(1A):31-5. PubMed ID: 2879461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of prazosin on hemodynamics, hemostasis, and serum lipid and lipoprotein levels in normal and hypercholesterolemic monkeys.
    Karge WH; Weiner EJ; Kowala MC; Graham RM; Nicolosi RJ
    Am J Med; 1989 Jan; 86(1B):19-23. PubMed ID: 2913768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of action of adrenergic receptor blockers on lipids during antihypertensive drug treatment.
    Rabkin SW
    J Clin Pharmacol; 1993 Mar; 33(3):286-91. PubMed ID: 8096525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of doxazosin on diet-induced hypercholesterolemia in C57BR/cdJ mice.
    Swindell AC; Valentine JJ
    Am J Cardiol; 1987 May; 59(14):29G-34G. PubMed ID: 2884850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Do beta blockers affect hypercholesterolemia treatment?].
    Richter WO; Ritter MM
    Med Monatsschr Pharm; 1991 Jan; 14(1):23-4. PubMed ID: 1673218
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical pharmacology of selective alpha blockers. Hemodynamics and effects on lipid levels.
    Reid JL; Elliott HL; Vincent J; Meredith PA
    Am J Med; 1987 Jan; 82(1A):15-20. PubMed ID: 3799697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sympathetic drive and vascular damage in hypertension and atherosclerosis.
    Pauletto P; Scannapieco G; Pessina AC
    Hypertension; 1991 Apr; 17(4 Suppl):III75-81. PubMed ID: 2013498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of sympathetic activity in atherogenesis: effects of beta-blockade.
    Ablad B; Björkman JA; Gustafsson D; Hansson G; Ostlund-Lindqvist AM; Pettersson K
    Am Heart J; 1988 Jul; 116(1 Pt 2):322-7. PubMed ID: 2899391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of the interaction of hypertension and hypercholesterolemia in atherogenesis: the effects of antihypertensive agents.
    Dzau VJ
    Am Heart J; 1988 Dec; 116(6 Pt 2):1725-8. PubMed ID: 3202079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative studies on the hypercholesterolaemia induced by excess dietary tyrosine or polychlorinated biphenyls in rats.
    Nagaoka S; Kato M; Aoyama Y; Yoshida A
    Br J Nutr; 1986 Sep; 56(2):509-17. PubMed ID: 2890372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A critical analysis of the role of cholesterol in atherogenesis.
    Sloop GD
    Atherosclerosis; 1999 Feb; 142(2):265-8. PubMed ID: 10030376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adrenergic mechanisms in control of plasma lipid concentrations.
    Lehtonen A
    Br Med J (Clin Res Ed); 1982 Jun; 284(6330):1708. PubMed ID: 6123362
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.